Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Véronique Chabert-Orsini"'
Autor:
Philippe Halfon, Claude Giorgetti, Hacène Khiri, Guillaume Pénaranda, Philippe Terriou, Géraldine Porcu-Buisson, Véronique Chabert-Orsini
Publikováno v:
PLoS ONE, Vol 5, Iss 5, p e10569 (2010)
BackgroundThe risk of male-to-female intravaginal HIV-1 transmission is estimated at about 1 event per 200-2000 coital acts. The aim of this study was to assess the residual risk of HIV presence in semen in patients under HAART therapy.Methods and fi
Externí odkaz:
https://doaj.org/article/c01e4b328ad1416d9ab44928bf630611
Autor:
Paul Barrière, Samir Hamamah, Elisangela Arbo, Catherine Avril, Bruno Salle, Jean-Luc Pouly, Julian Jenkins, Collaborators - Members of the REOLA Study Group: Sylvia Alvarez, Tal Anahory, François-Xavier Aubriot, Nadia Kazdar, Véronika Grzegorczyk-Martin, Joelle Belaisch-Allart, Véronique Chabert-Orsini, Géraldine Porcu-Buisson, Charles Chapron, Blandine Courbiere, Christine Decanter, Michael Grynberg, Claude Hocké, Nathalie Massin, Isabelle Parneix, Paul Sagot, Bruno Salle Bruno
Publikováno v:
Journal of Gynecology Obstetrics and Human Reproduction. 52:102510
Background Since the first launch of a biosimilar recombinant follicle stimulating hormone (rFSH), Bemfola®, in Europe in 2014, it has been possible to study in routine clinical care throughout France the effectiveness of a biosimilar rFSH including
Publikováno v:
Reproductive biomedicine online. 7(2)
The objective of this study was to compare, in a centre with previous experience of gonadotrophin-releasing hormone (GnRH) antagonist use, single administration of a GnRH antagonist [cetrorelix (Cetrotide) 3 mg] with a single administration of a GnRH